NetworkNewsBreaks – INmune Bio, Inc.’s (NASDAQ: INMB) XPro1595 Featured in Poster Presentation at The European Conference on Neuroinflammation
INmune Bio (NASDAQ: INMB) this morning announced that Lesley Probert, Ph.D., Head of Immunology Department at the Hellenic Pasteur Institute in Athens, Greece, will be presenting a poster about new data on INmune’s neurodegenerative disease drug candidate XPro1595 at The European Conference on Neuroinflammation on April 8th and 9th. The presentation is titled “Selective inhibition of soluble TNF promotes macrophage phagocytosis of myelin debris and remyelination of demyelinated lesions” and will shine a light on how XPro1595 promotes remyelination in animal models of Multiple Sclerosis (“MS”), as demonstrated in Dr. Probert’s earlier work. “The work done by Dr. Probert and…







